Comparison of the genotoxic activities of the K-region dihydrodiol of benzo[a]pyrene with benzo[a]pyrene in mammalian cells: Morphological cell transformation; DNA damage; and stable covalent DNA adducts

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 521, Issue 1-2, 2002, Pages 91-102

  Nesnow, Stephen ^a   Davis, Christine ^a   Nelson, Garret B ^a   Lambert, Guy ^a   Padgett, William ^a   Pimentel, Maria ^a   Tennant, Alan H ^a   Kligerman, Andrew D ^a   Ross, Jeffrey A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

32P postlabeling; Benzo a pyrene 4,5 dihydrodiol; C3H10T1 2 cells; Comet assay; DNA adducts; K region; Morphological cell transformation

Indexed keywords

BENZO[A]PYRENE; BENZO[A]PYRENE DERIVATIVE; DNA;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL LINE; CELL STRUCTURE; CELL TRANSFORMATION; COMET ASSAY; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; DNA DETERMINATION; DOSE RESPONSE; GENOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STRUCTURE ANALYSIS;

ANIMALS; BENZO(A)PYRENE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COMET ASSAY; DIHYDROXYDIHYDROBENZOPYRENES; DNA ADDUCTS; DNA DAMAGE; EMBRYO; FIBROBLASTS; ISOTOPE LABELING; MAMMALS; MICE; MUTAGENICITY TESTS; PHOSPHORUS RADIOISOTOPES;

ANIMALIA; MAMMALIA;

EID: 0037180363     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00218-8     Document Type: Article

References (47)

1. Nesnow S., Davis C., Padgett W., Adams L., King L.C. 8,9-Dihydroxy-8,9-dihydrodibenzo[a,l]pyrene is a potent morphological cell transforming agent in C3H10T1/2CL8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts. Carcinogenesis. 21:2000;1253-1257.
2. Davis C., Nesnow S., Desai D., Amin S. Evaluation of benzo[c]chrysene dihydrodiols in the morphological cell transformation of mouse embryo fibroblast C3H10T1/2CL8 cells. Polycyclic Arom. Comp. 21:2000;203-213.
3. Nesnow S., Huisingh J., Bergman H., Easterling R., Inmon J., King L., Morris M.S., Williams K., Hyatt B., Montgomery L., Cudak C. Carcinogen metabolism in rat liver cell culture. Ann. N. Y. Acad. Sci. 349:1980;247-263.
4. Fahl W.E., Nesnow S., Jefcoate C.R. Microsomal metabolism on benzo[a]pyrene. Multiple effects of epoxide hydrase inhibitors. Arch. Biochem. Biophys. 181:1977;649-664.
5. Jones C.A., Moore B.P., Cohen G.M., Fry J.R., Bridges J.W. Studies on the metabolism and excretion of benzo[a]pyrene in isolated adult rat hepatocytes. Biochem. Pharmacol. 27:1978;693-702.
6. Bauer E., Guo Z., Ueng Y.F., Bell L.C., Zeldin D., Guengerich F.P. Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8:1995;136-142.
7. Shou M., Grogan J., Mancewicz J.A., Krausz K.W., Gonzalez F.J., Gelboin H.V., Korzekwa K.R. Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry. 33:1994;6450-6455.
8. Shou M., Korzekwa K.R., Crespi C.L., Gonzalez F.J., Gelboin H.V. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinog. 10:1994;159-168.
9. Rudo K., Ellis S., Bryant B.J., Lawrence K., Curtis G., Garland H., Nesnow S. Quantitative analysis of the metabolism of benzo[a]pyrene by transformable C3H10T1/2CL8 mouse embryo fibroblasts. Teratog. Carcinog. Mutagen. 6:1986;307-319.
10. Shimada T., Gillam E.M., Oda Y., Tsumura F., Sutter T.R., Guengerich F.P., Inoue K. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 12:1999;623-629.
11. Savas U., Carstens C.P., Jefcoate C.R. Biological oxidations and P450 reactions. Recombinant mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Arch. Biochem. Biophys. 347:1997;181-192.
12. Shen Z., Liu J., Wells R.L., Elkind M.M. cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P450 gene, Cyp1b1. DNA Cell Biol. 13:1994;763-769.
13. Wood A.W., Goode R.L., Chang R.L., Levin W., Conney A.H., Yagi H., Dansette P.M., Jerina D.M. Mutagenic and cytotoxic activity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides and the six corresponding phenols. Proc. Natl. Acad. Sci. U.S.A. 72:1975;3176-3180.
14. Levin W., Wood A.W., Yagi H., Dansette P.M., Jerina D.M., Conney A.H. Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skin. Proc. Natl. Acad. Sci. U.S.A. 73:1976;243-247.
15. Chouroulinkov I., Gentil A., Grover P.L., Sims P. Tumour-initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyrene. Br. J. Cancer. 34:1976;523-532.
16. Wood A.W., Levin W., Lu A.Y., Yagi H., Hernandez O., Jerina D.M., Conney A.H. Metabolism of benzo[a]pyrene and benzo[a]pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J. Biol. Chem. 251:1976;4882-4890.
17. Mager R., Huberman E., Yang S.K., Gelboin H.V., Sachs L. Transformation of normal hamster cells by benzo[a]pyrene diol-epoxide. Int. J. Cancer. 19:1977;814-817.
18. Marquardt H., Grover P.L., Sims P. In vitro malignant transformation of mouse fibroblasts by non-K-region dihydrodiols derived from 7-methylbenz[a]anthracene, 7,12-dimethylbenz[a]anthracene, and benzo[a]pyrene. Cancer Res. 36:1976;2059-2064.
19. Nesnow S., Davis C., Padgett W., George M., Lambert G., Meyers F., Allison J., Adams L., King L.C. Metabolic activation of racemic and enantiomeric trans-8,9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts. Chem. Res. Toxicol. 11:1998;1596-1607.
20. Reznikoff C.A., Brankow D.W., Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33:1973;3231-3238.
21. Reznikoff C.A., Bertram J.S., Brankow D.W., Heidelberger C. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33:1973;3239-3249.
22. Nesnow S., Davis C., Nelson G., Ross J.A., Allison J., Adams L., King L.C. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts. Carcinogenesis. 18:1997;1973-1978.
23. Martin F.L., Cole K.J., Orme M.H., Grover P.L., Phillips D.H., Venitt S. The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single-cell gel electrophoresis 'comet' assay in metabolically-competent MCL-5 cells. Mutat. Res. 445:1999;21-43.
24. Ross J.A., Nelson G.B., Holden K.L. DNA isolation from small tissue samples using salt and spermine. Nucleic Acids Res. 19:1991;6053.
25. Padgett W.T., Davis C., Lambert G., Nelson G.B., Ross J.A., Yacopucci M., Nesnow S. Biotransformation of trans-4,5-dihydroxy-4,5-dihydrobenzo[a]pyrene to benzo[a]pyrene bis-diols and DNA adducts by induced rat liver microsomes. Chem. Res. Toxicol. 13:2000;1125-1134.
26. 32P -postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts Carcinogenesis. 3:1982;1081-1092.
27. 32P -postlabeling test for structurally diverse DNA adducts Carcinogenesis. 7:1986;1543-1551.
28. 32P -adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures Carcinogenesis. 9:1988;1687-1693.
29. Prahalad A.K., Ross J.A., Nelson G.B., Roop B.C., King L.C., Nesnow S., Mass M.J. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis. 18:1997;1955-1963.
30. Gehly E.B., Fahl W.E., Jefcoate C.R., Heidelberger C. The metabolism of benzo[α]pyrene by cytochrome P450 in transformable and nontransformable C3H mouse fibroblasts. J. Biol. Chem. 254:1979;5041-5048.
31. Nesnow S., Davis C., Pimentel M., Mass M.J., Nelson G.B., Ross J.A. Interaction analyses of binary mixtures of carcinogenic PAHs using morphological cell transformation of C3H10T1/2CL8 mouse embryo fibroblasts in culture. Polycyclic Arom. Comp. 21:2000;31-42.
32. J.W. Cook, C.L. Hewitt, I. Heiger, The isolation of a cancer producing hydrocarbon from coal tar, J. Chem. Soc. (1933) 395-405.
33. M.R. Osborne, N.T. Crosby Benzopyrenes, Cambridge University Press, Cambridge, UK, 1987.
34. Petruzzelli S., Celi A., Pulera N., Baliva F., Viegi G., Carrozzi L., Ciacchini G., Bottai M., Di Pede F., Paoletti P., Giuntini C. Serum antibodies to benzo[a]pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases. Cancer Res. 58:1998;4122-4126.
35. Cavalieri E.L., Rogan E.G. Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica. 25:1995;677-688.
36. Penning T.M., Burczynski M.E., Hung C.F., McCoull K.D., Palackal N.T., Tsuruda L.S. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem. Res. Toxicol. 12:1999;1-18.
37. Ross J.A., Nesnow S. Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat. Res. 424:1999;155-166.
38. Pullman A. Structure electronique et pouvoir cancerigene des hydrocarbures aromatiques condenses. Bull. Assoc. Franc. Cancer. 33:1946;120-130.
39. Cavalieri E.L., Higginbotham S., RamaKrishna N.V., Devanesan P.D., Todorovic R., Rogan E.G., Salmasi S. Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis. 12:1991;1939-1944.
40. Slaga T.J., Bracken W.M., Viaje A., Berry D.L., Fischer S.M., Miller D.R., Levin W., Conney A.H., Yagi H., Jerina D.M. Tumor initiating and promoting activities of various benzo[a]pyrene metabolites in mouse skin. Carcinog. Comp. Surv. 3:1978;371-382.
41. Arce G.T., Allen J.W., Doerr C.L., Elmore E., Hatch G.G., Moore M.M., Sharief Y., Grunberger D., Nesnow S. Relationships between benzo[a]pyrene-DNA adduct levels and genotoxic effects in mammalian cells. Cancer Res. 47:1987;3388-3395.
42. Benedict W.F., Banerjee A., Venkatesan N. Cyclophosphamide-induced oncogenic transformation, chromosomal breakage, and sister chromatid exchange following microsomal activation. Cancer Res. 38:1978;2922-2924.
43. Fortini P., Raspaglio G., Falchi M., Dogliotti E. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis. 11:1996;169-175.
44. Nesnow S., Leavitt S., Garland H., Vaughan T.O., Hyatt B., Montgomery L., Cudak C. Identification of cocarcinogens and their potential mechanisms of action using C3H10T1/2CL8 mouse embryo fibroblasts. Cancer Res. 41:1981;3071-3076.
45. Hanelt S., Helbig R., Hartmann A., Lang M., Seidel A., Speit G. A comparative investigation of DNA adducts, DNA strand breaks and gene mutations induced by benzo[a]pyrene and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-oxide in cultured human cells. Mutat. Res. 390:1997;179-188.
46. Flowers L., Bleczinski W.F., Burczynski M.E., Harvey R.G., Penning T.M. Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase. Biochemistry. 35:1996;13664-13672.
47. Gehly E.B., Landolph J.R., Heidelberger C., Nagasawa H., Little J.B. Induction of cytotoxicity, mutation, cytogenetic changes, and neoplastic transformation by benzo[a]pyrene and derivatives in C3H/10T1/2 clone eight mouse fibroblasts. Cancer Res. 42:1982;1866-1875.